The 2009 American Thyroid Association Guidelines Modestly Reduced Radioactive Iodine Use for Thyroid Cancers Less Than 1 cm
Overview
Authors
Affiliations
Yancheshmeh S, Firouzfar A, Nazem M, Yancheshmeh S, Pouramini A, Mansourian M J Res Med Sci. 2023; 28:63.
PMID: 38024514 PMC: 10668217. DOI: 10.4103/jrms.jrms_191_22.
Husain S, Lohia S, Petkov V, Blackwell T, Swisher-McClure S, Mizrachi A Head Neck. 2021; 43(7):2110-2123.
PMID: 33851469 PMC: 9405436. DOI: 10.1002/hed.26679.
Thyroid cancer burden and economic impact on the Brazilian public health system.
Janovsky C, Bittencourt M, Pires de Novais M, Maciel R, Biscolla R, Zucchi P Arch Endocrinol Metab. 2018; 62(5):537-544.
PMID: 30462807 PMC: 10118657. DOI: 10.20945/2359-3997000000074.
Pilot Study of a Web-based Decision Tool on Post-operative Use of Radioactive Iodine.
Baxi S, Kurtzman R, Eaton A, Dewey E, Bickford C, Fish S Eur Endocrinol. 2018; 13(1):26-29.
PMID: 29632603 PMC: 5813442. DOI: 10.17925/EE.2017.13.01.26.
Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer.
Molenaar R, Sidana S, Radivoyevitch T, Advani A, Gerds A, Carraway H J Clin Oncol. 2017; 36(18):1831-1839.
PMID: 29252123 PMC: 8462524. DOI: 10.1200/JCO.2017.75.0232.